Sai Life Sciences Ltd. SAILIFE.NS · Stock Open Sai Life Sciences Ltd. in new tab
Analyst price targets
Recent rating changes, newest first
Sai Life Sciences Ltd. Analysis (SAILIFE.NS)
Is Sai Life Sciences Ltd. a good investment? Sai Life Sciences Ltd. (SAILIFE.NS) is currently trading at 1471.30 INR. Market analysts have a consensus price target of 1552.67 INR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 87.83. This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule: Sai Life Sciences Ltd. is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is 24.98.
Investor FAQ
Does Sai Life Sciences Ltd. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Sai Life Sciences Ltd.?
Sai Life Sciences Ltd. is classified as a Stock.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 16.93.
Company Profile
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.
Community Discussion